Product description
Fiasp FlexTouch
ARTG 275394
(Fiasp FlexTouch insulin aspart (rys) 100 units/mL solution for injection 3mL pre-filled pen)
Batch numbers:
LP58119 expiry date 30/09/2023
LP58452 expiry date 30/09/2023
See a list of details to help identify the product
Reason the product is recalled
The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states:
- ‘Do not keep the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you.
The storage conditions are correctly stated on the product carton. The correct statement reads:
- ‘You can carry the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’
The hazards to consumers
Storing the product at incorrect temperatures may result in reduced effectiveness, which may increase the risk of adverse health effects.
What consumers should do
Consumers should follow the instructions on the carton which indicate you can carry the Fiasp® FlexTouch® you are using, or carrying as a spare, either below 30°C or in a refrigerator (2°C - 8°C).
Consumers can obtain a current Consumer Medicine Information leaflet from a pharmacist or visit the TGA website at https://www.ebs.tga.gov.au/
For further information, contact NovoNordisk Customer Service by phone on 1800 668 626.
Details to help identify the product
Supplier running the recall
Who sold the product
Pharmacies and distributors
Identifying numbers
Barcode number
Dates available for sale
Where the product was sold
Manufacturer country ID
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2021/19259 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.